ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/19/2025
Back to search
Official data from USPTO
WILSHIRE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
WILSHIRE PHARMACEUTICALS
ST13
US500000085749031Class
5
Filing
85749031
Registration
4564923
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/20/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/09/2012
Registration date
07/08/2014
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2024
Last transaction
03/20/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/24/2010
First use in commerce
02/24/2010
Drawing code
4
Owner type
03
Owner location
Atlanta, GA
Examiner
VAGHANI, MAYUR
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Wilshire Pharmaceuticals, Inc.
Representatives
Elizabeth M. Fox KING & SPALDING LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
House mark for a full line of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
38 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/02/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/02/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/02/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/02/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/07/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/08/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/31/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/31/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/28/2020
E815
TEAS SECTION 8 & 15 RECEIVED
06/10/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/08/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/25/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/03/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/31/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/29/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/21/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/20/2014
IUAF
USE AMENDMENT FILED
04/25/2014
EISU
TEAS STATEMENT OF USE RECEIVED
04/25/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/10/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2013
PUBO
PUBLISHED FOR OPPOSITION
10/15/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/06/2013
ALIE
ASSIGNED TO LIE
09/06/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/13/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2013
GNRT
NON-FINAL ACTION E-MAILED
02/06/2013
CNRT
NON-FINAL ACTION WRITTEN
02/06/2013
DOCK
ASSIGNED TO EXAMINER
02/06/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2012
NWAP
NEW APPLICATION ENTERED
10/12/2012
Continuous trademark protection
Get notified about every new filing that threatens WILSHIRE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.